Skip to content

Opening book details…

Can I read Optimization of storage conditions for diluted working solutions of porcine factor VIII and performance of the Bethesda assay for the determination of antiporcine FVIII inhibitor titres on EtoBox?

Optimization of storage conditions for diluted working solutions of porcine factor VIII and performance of the Bethesda assay for the determination of antiporcine FVIII inhibitor titres by R. Winikoff; A. Boulanger; P. Robinson; J. ST‐Louis; S. Lacroix; G.‐É. Rivard is a Medicine article available to read on EtoBox.

What is Optimization of storage conditions for diluted working solutions of porcine factor VIII and performance of the Bethesda assay for the determination of antiporcine FVIII inhibitor titres about?

**Summary.** The use of porcine factor VIII (FVIII) (Hyate:C, Ipsen) has proven to be very successful in treating patients with FVIII inhibitors. The best way to predict the usefulness of porcine FVIII therapy, and/or to estimate the appropriate treatment dose in a given patient, is to measure the patient inhibitor titre against porcine FVIII with the Bethesda assay, using porcine FVIII as the source of FVIII in the assay. The goals of the present study were to (1) find the optimal storage temperature, diluent and concentration for a working solution of porcine FVIII to be used as the source of FVIII for the porcine Bethesda assay, (2) assess the reliability of the labelled FVIII units in the preparation of such working solutions of porcine FVIII and (3) compare the inhibitor titres determined by the Bethesda assay using both porcine and human standard reference curves for measuring residual FVIII. The results of the present study demonstrate that a ready‐to‐use working solution of 1 U mL^−1^ of Hyate:C diluted in human FVIII deficient plasma, either containing or deficient in von Willebrand factor antigen, is stable for up to 12 months, at −20 °C. The preparation of the 1 U mL^−1^

Who reads Optimization of storage conditions for diluted working solutions of porcine factor VIII and performance of the Bethesda assay for the determination of antiporcine FVIII inhibitor titres?

It is typically read by researchers, students, and practitioners in Medicine.

Author
R. Winikoff; A. Boulanger; P. Robinson; J. ST‐Louis; S. Lacroix; G.‐É. Rivard
Publisher
John Wiley and Sons; Wiley (Blackwell Publishing); Blackwell Publishing Inc.; Wiley (ISSN 1351-8216)
Published
2003
Language
EN
Field
Medicine (Health Sciences)

More by R. Winikoff; A. Boulanger; P. Robinson; J. ST‐Louis; S. Lacroix; G.‐É. Rivard

Browse all works by R. Winikoff; A. Boulanger; P. Robinson; J. ST‐Louis; S. Lacroix; G.‐É. Rivard